Under most circumstances, stock picking is difficult, and that difficulty level is ratcheted higher in the disruptive technology space. That’s certainly true of genomics investing where fortunes are burned and minted on the back of clinical trial success. That is to say that the rosters of many genomics exchange traded funds may be homes to [...] The post This Stock Could Propel Genomics ETFs appeared first on ETF Trends .